3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
8
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
15
Colorectal Neoplasms
13
Lung Neoplasms
12
Neoplasms
11
Stomach Neoplasms
9
Neoplasm Metastasis
6
Colonic Neoplasms
6
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Ovarian Neoplasms
3
Osteosarcoma
3
Multiple Myeloma
3
Melanoma
3
Lymphoma, Follicular
3
Lymphoma
3
Waldenstrom Macroglobulinemia
2
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Rectal Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
9
Blood Specimen Collection
9
Radiotherapy
7
Surveys and Questionnaires
6
Surgical Procedures, Operative
4
vorasidenib
3
Temozolomide
3
Aminolevulinic Acid
3
X-Rays
2
Watchful Waiting
2
Polymerase Chain Reaction
2
Neuropsychological Tests
2
Mental Status and Dementia Tests
2
Magnetic Resonance Imaging
2
Fluorodeoxyglucose F18
2
Diagnostic Imaging
2
Cancer Vaccines
2
Amplified Fragment Length Polymorphism Analysis
2
vinyltriethoxysilane
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
gadoterate meglumine
1
gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
1
fluorodopa F 18
1
fluarix
1
apatinib
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Trail Making Test
1
Tetanus Toxoid
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Glioma
×
Drug Therapy
×
Clear all
NCT06102837
2023-10-26
Tumor Vaccines for Solid Tumors
Huashan Hospital
Recruiting
340 enrolled